53 results
10-K
2020 FY
EX-4.3
NRIX
Nurix Therapeutics Inc
16 Feb 21
Annual report
4:11pm
of incorporation, which means that holders of a majority of the shares of our common stock are able to elect all of our directors. Our restated certificate … . In addition, the
number of directors constituting our board of directors is permitted to be set only by a resolution adopted by a majority vote of our entire
DRS
EX-3.3
NRIX
Nurix Therapeutics Inc
5 May 20
Draft registration statement
12:00am
Executive Officer, (iii) the Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directors (whether … , if applicable, or by proxy duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote shall constitute
S-1
EX-3.3
NRIX
Nurix Therapeutics Inc
2 Jul 20
IPO registration
4:04pm
Executive Officer, (iii) the Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directors (whether … , if applicable, or by proxy duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote shall constitute a quorum
S-1/A
EX-3.1
NRIX
Nurix Therapeutics Inc
20 Jul 20
IPO registration (amended)
6:32am
by the terms of
this Certificate of Incorporation) the affirmative vote of the holders of shares of capital stock of the Company representing a majority … required herein or by law) the written consent or affirmative vote of the holders of a majority of the then outstanding shares of Series Preferred, given
S-1
EX-3.1
NRIX
Nurix Therapeutics Inc
2 Jul 20
IPO registration
4:04pm
by the terms of
this Certificate of Incorporation) the affirmative vote of the holders of shares of capital stock of the Company representing a majority … or by law) the written consent or affirmative vote of the holders of a majority of the then outstanding shares of Series Preferred, given in writing
S-1/A
EX-3.2
8deb6rtwym
20 Jul 20
IPO registration (amended)
6:32am
10-Q
EX-3.1
d1ux76
14 Oct 20
Quarterly report
4:02pm
10-Q
EX-3.2
b5orx5cz
14 Oct 20
Quarterly report
4:02pm
S-1/A
EX-3.4
lg9rozjbe09mfj c6w
20 Jul 20
IPO registration (amended)
6:32am
S-3ASR
EX-4.3
lzo49pj9m7tl2
4 Aug 21
Automatic shelf registration
4:11pm
8-K
EX-3.1
pyzyfc
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
424B5
bcf9ye
8 Jul 22
Prospectus supplement for primary offering
4:09pm
424B5
o2k9wdlasakq9pp
8 Jul 22
Prospectus supplement for primary offering
4:10pm
S-3ASR
7tbz1n avh2x
4 Aug 21
Automatic shelf registration
4:11pm
S-1
EX-10.1
jk1pinmz7f 9ntn3p1
2 Jul 20
IPO registration
4:04pm
S-1
EX-4.2
4qshxhdqs0j3
2 Jul 20
IPO registration
4:04pm
DRS
EX-4.2
esbmd4
5 May 20
Draft registration statement
12:00am
S-3ASR
EX-4.4
x0ifbvj
4 Aug 21
Automatic shelf registration
4:11pm
424B5
fxjvq5
12 Apr 24
Prospectus supplement for primary offering
5:10pm
424B5
c3qqp59j3 cws
11 Apr 24
Prospectus supplement for primary offering
4:06pm